Pai, Sheetal S <br/><br/>
Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.  [electronic resource] 

 -  The AAPS journal  Mar 2009 
 - 88-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review 
<br/><br/><label>ISSN: </label>1550-7416 
<br/><br/><label>Standard No.: </label>10.1208/s12248-009-9081-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adsorption<br/>Delayed-Action Preparations<br/>Drug Carriers<br/>Drug Compounding<br/>Drug Stability<br/>Gels<br/>Half-Life<br/>Human Growth Hormone--administration & dosage<br/>Humans<br/>Injections, Subcutaneous<br/>Lactic Acid--pharmacokinetics<br/>Microspheres<br/>Muramidase--administration & dosage<br/>Peptides--administration & dosage<br/>Polyethylene Glycols--pharmacokinetics<br/>Polyglycolic Acid--pharmacokinetics<br/>Polylactic Acid-Polyglycolic Acid Copolymer<br/>Protein Stability<br/>Proteins--administration & dosage<br/>Silicon Dioxide<br/>Solvents--pharmacology